Gufic Biosciences Ltd

GUFICBIO

Company Profile

  • Business description

    Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.

  • Contact

    SM House, 11 Sahakar Road
    1st to 4th Floor
    Vile Parle (East)
    MumbaiMH400 057
    IND

    T: +91 2267261000

    https://www.gufic.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    2,926

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,314.8017.10-0.18%
CAC 408,258.8652.790.64%
DAX 4024,330.0371.230.29%
Dow JONES (US)46,924.74218.160.47%
FTSE 1009,426.9923.420.25%
HKSE25,697.57329.98-1.27%
NASDAQ22,953.6736.88-0.16%
Nikkei 22549,372.6856.620.11%
NZX 50 Index13,306.4471.41-0.53%
S&P 5006,735.350.220.00%
S&P/ASX 2009,026.3014.00-0.15%
SSE Composite Index3,899.0517.28-0.44%

Market Movers